Content about Francisco

May 15, 2013

FDA approves Genentech drug for lung cancer with genetic mutation

The Food and Drug Administration has approved a drug for a type of lung cancer.

SOUTH SAN FRANCISCO, Calif. — The Food and Drug Administration has approved a drug for a type of lung cancer.

Roche subsidiary Genentech and the U.S. subsidiary of Japan's Astellas Pharma announced the approval of Tarceva (erlotinib) for advanced non-small cell lung cancer whose tumors have mutations that activate the epidermal growth factor receptor. The FDA also approved a test to detect the mutation.

The drug was already approved for advanced NSCLC that did not exhibit the mutation.

April 30, 2013

FDA approves Genentech arthritis drug for rare disorder in children

The Food and Drug Administration has approved a drug made by Genentech for a rare form of arthritis in children, the company said Tuesday.

SOUTH SAN FRANCISCO, Calif. — The Food and Drug Administration has approved a drug made by Genentech for a rare form of arthritis in children, the company said Tuesday.

Genentech, a subsidiary of Swiss drug maker Roche, announced the approval of Actemra (tocilizumab) for polyarticular juvenile idiopathic arthritis in children ages 2 years and older, either alone or combined with the generic drug methotrexate.

October 12, 2012

FDA approves new use for Genentech arthritis drug

The Food and Drug Administration has approved a new use for a drug made by Roche division Genentech.

SOUTH SAN FRANCISCO, Calif. — The Food and Drug Administration has approved a new use for a drug made by Roche division Genentech.

The drug maker said Friday that the FDA had approved Actemra (tocilizumab) for adults with moderately to severely active rheumatoid arthritis who have not responded adequately to one or more disease-modifying antirheumatic drugs. The drug was already approved for systemic juvenile idiopathic arthritis.

October 10, 2012

Petroleum jelly alternative Waxelene expands distribution to Bed Bath & Beyond

Waxelene, a petroleum jelly alternative, now is being sold in Bed Bath & Beyond retail stores, the company has announced.

SAN FRANCISCO, Calif. — Waxelene, a petroleum jelly alternative, now is being sold in Bed Bath & Beyond retail stores, the company has announced. This brings the total count of retail outlets carrying Waxelene to more than 800 across all 50 U.S. states and Canada.

November 28, 2011

Zion Health launches clay body care line at Whole Foods in San Rafael, Calif.

Zion Health, a maker of natural minerals skin care products, has announced the launch of its Adama Minerals clay body care line at Whole Foods in San Rafael, Calif.

SAN FRANCISCO, Calif. — Zion Health, a maker of natural minerals skin care products, has announced the launch of its Adama Minerals clay body care line at Whole Foods in San Rafael, Calif.

The announcement comes on the heels of a recent agreement with Willner Chemists Health Food Store to offer Zion Health’s complete Adama line at its Chicago stores.